Alkem Executive and Leadership Team

Ravindra Sharma, the Chief Executive Officer at Alkem, directs the overarching corporate strategy and long-term vision for the organization. Sharma manages the alignment of manufacturing capabilities with global market demands, ensuring the company maintains a competitive edge in the pharmaceutical sector. By overseeing the integration of research initiatives with commercial objectives, the Chief Executive Officer drives sustainable growth across international territories. This leadership role involves constant collaboration with the Board to refine operational efficiency and expand the reach of nutraceutical products. Ravindra Sharma monitors key performance indicators to ensure the company meets rigorous quality standards while scaling production capacity. Through disciplined resource allocation and a focus on innovation, the Chief Executive Officer secures the company's position as a leader in the global healthcare landscape, consistently delivering value to stakeholders and patients alike.

Yugandhara Hiray, the Manager - Strategy and CEO's Chief of Staff at Alkem, coordinates strategic initiatives and facilitates communication between the executive office and departmental leaders. Hiray manages the execution of high-priority projects, ensuring alignment with the company's long-term goals in the pharmaceutical and nutraceutical sectors. By overseeing cross-functional collaboration, the Manager - Strategy and CEO's Chief of Staff optimizes internal processes to improve organizational agility. This role involves synthesizing complex data into actionable insights for the Chief Executive Officer, enabling informed decision-making on market expansion and product development. Yugandhara Hiray monitors the progress of key strategic objectives, identifying potential bottlenecks and implementing solutions to maintain operational momentum. Through the management of executive workflows and strategic planning, the Manager - Strategy and CEO's Chief of Staff ensures that the company remains focused on its core mission of providing accessible healthcare solutions globally.

Rajesh Dubey, the Chief Financial Officer at Alkem, manages the financial health and fiscal planning of the entire organization. Dubey oversees capital allocation, budgeting, and financial reporting, ensuring transparency and compliance across all global operations. By analyzing market trends and economic indicators, the Chief Financial Officer optimizes the company's investment strategies to support research and development projects. This role requires close coordination with executive leadership to mitigate financial risks and enhance profitability in the competitive pharmaceutical market. Rajesh Dubey directs the financial planning processes that underpin the company's expansion into new regions, providing the necessary capital structure for sustained growth. Through rigorous oversight of fiscal policies and internal controls, the Chief Financial Officer maintains the financial stability required to support the company's mission of delivering high-quality healthcare products to a diverse international patient base.

Ashish Sehgal, the President, Research Development, Regulatory Affairs & International Portfolio at Alkem, directs the innovation pipeline and ensures compliance with global regulatory standards. Sehgal oversees the development of new pharmaceutical formulations, managing the transition from laboratory research to commercial production. By leading regulatory affairs, the President, Research Development, Regulatory Affairs & International Portfolio secures necessary approvals for market entry across diverse international jurisdictions. This role involves managing the international portfolio to maximize the impact of the company's product offerings in various healthcare markets. Ashish Sehgal coordinates with research teams to prioritize projects that address unmet medical needs, driving the company's growth through scientific advancement. Through the strategic management of development cycles and regulatory compliance, the President, Research Development, Regulatory Affairs & International Portfolio ensures that the company consistently delivers safe, effective, and high-quality products to patients worldwide.

Manish Narang, the President & Legal, Company Secretary & At Alkem Laboratories Limited Compliance Officer at Alkem, directs the legal framework and corporate governance standards for the entire organization. Narang oversees all legal affairs, ensuring that business operations adhere to international laws and industry-specific regulations. By managing the company's compliance programs, the President & Legal, Company Secretary & At Alkem Laboratories Limited Compliance Officer mitigates legal risks and upholds the highest standards of corporate integrity. This role involves providing counsel to the Board and executive leadership on complex legal matters, including intellectual property protection and contractual agreements. Manish Narang coordinates with regulatory bodies to ensure transparency and accountability in all corporate activities. Through the diligent oversight of legal and compliance functions, the President & Legal, Company Secretary & At Alkem Laboratories Limited Compliance Officer protects the company's reputation and supports its mission of delivering reliable healthcare solutions globally.

Durai Srinivasan, the Global President, Procurement Api Business & Operations at Alkem, directs the procurement strategies and operational efficiency of the Active Pharmaceutical Ingredient business. Srinivasan oversees the global supply chain, ensuring the consistent availability of high-quality raw materials for manufacturing processes. By managing vendor relationships and optimizing procurement costs, the Global President, Procurement Api Business & Operations enhances the company's competitive position in the pharmaceutical market. This role involves coordinating with production teams to ensure that operational workflows meet global demand for nutraceutical and pharmaceutical products. Durai Srinivasan drives initiatives to improve supply chain resilience and sustainability, supporting the company's commitment to reliable healthcare delivery. Through the strategic management of procurement and operational activities, the Global President, Procurement Api Business & Operations ensures that the company maintains the necessary resources to support its extensive international product portfolio.

Shirish Ambulgekar, the President at Alkem, directs specific business units focused on expanding the company's market presence and operational reach. Ambulgekar oversees the execution of commercial strategies, ensuring that product lines meet the evolving needs of healthcare providers and patients. By managing cross-functional teams, the President drives the implementation of sales and marketing initiatives that support the company's growth objectives. This role involves analyzing market dynamics to identify new opportunities for product penetration and brand development. Shirish Ambulgekar coordinates with other executive leaders to ensure that business unit activities align with the overall corporate mission of delivering high-quality pharmaceutical products. Through the strategic leadership of these business units, the President contributes to the company's success in diverse global markets, consistently focusing on operational excellence and the delivery of value-driven healthcare solutions to a broad international customer base.

Sunil Pathak, the President, Semi Chronic Business, Oncology, Biosimilar at Alkem, directs the strategic development and commercialization of specialized therapeutic portfolios. Pathak oversees the growth of the oncology and biosimilar segments, ensuring that these critical products reach patients in need across global markets. By managing the semi-chronic business unit, the President, Semi Chronic Business, Oncology, Biosimilar drives innovation in treatment options and enhances the company's therapeutic impact. This role involves collaborating with research and development teams to bring advanced medical solutions to market while maintaining high standards of efficacy and safety. Sunil Pathak monitors market trends in oncology and biosimilars to refine product positioning and expand the company's reach. Through the strategic management of these specialized business areas, the President, Semi Chronic Business, Oncology, Biosimilar ensures that the company remains at the forefront of medical innovation, providing essential healthcare solutions to patients worldwide.

Ramanarayana Parhi, the Vice President & Chief Information Officer at Alkem, architects the digital infrastructure and technological framework supporting global pharmaceutical manufacturing. Parhi directs the implementation of advanced data analytics and secure information systems to streamline supply chain operations and research workflows. By overseeing the digital transformation of internal processes, the Vice President & Chief Information Officer ensures seamless connectivity across international facilities. This leadership role involves managing cybersecurity protocols and IT governance to protect sensitive intellectual property and patient data. Ramanarayana Parhi drives the adoption of emerging technologies to enhance operational efficiency and decision-making capabilities throughout the organization. Through the strategic deployment of robust IT solutions, the Vice President & Chief Information Officer supports the company's commitment to innovation, ensuring that technological advancements directly contribute to the successful delivery of pharmaceutical products to global markets.